WAM

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Retrieved on: 
Wednesday, March 27, 2024
Research, NCI, AON, Development, Sarcoma, Disease, Neuroblastoma, Shareholder, Patient, CNS, Fast Track, Cash, SBIR, NDA, Syndrome, Cancer, MRR, CLR, BNS, University, Head, External beam radiotherapy, Cure, Wisconsin Alumni Research Foundation, WAM, HERE, Completeness, Safety, Tat, Intellectual property, Patent, PLE, WARF, Symantec Endpoint Protection, Tranche, UW, Pharmaceutical industry

FLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • FLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2023, and provided a corporate update.
  • Net cash used in operating activities during the twelve months ended December 31, 2023, was approximately $32.4 million.
  • General and Administrative Expense: G&A expense for the year ended December 31, 2023, was $10.7 million, compared to $9.6 million for the year ended December 31, 2022.
  • Cellectar management will host a conference call for investors today, March 14, 2024, beginning at 8:30 am Eastern Time to discuss these results and answer questions.

New Strata Cookbook and Identity Orchestration Recipes Automate Microsoft Active Directory Modernization and Coexistence with Microsoft Entra ID

Retrieved on: 
Thursday, March 21, 2024
Data Management, Security, Apps, Applications, Technology, Software, Networks, Internet, Microsoft, Organization, Directory, MFA, Active Directory, IDP, Entra, Internally displaced person, First officer (aviation), Microsoft Windows, WAM, Cookbook, SSO, Okta, Security association, Kerberos, MISA, Video game

Strata Identity , the Identity Orchestration company, today announced a new Microsoft Identity Cookbook, which includes several Orchestration Recipes that manage the complex identity relationships and processes for moving Windows applications from Microsoft Active Directory (AD) to cloud-based Microsoft Entra ID and extending Microsoft Entra ID to on-premises legacy Windows apps that do not support modern cloud identity protocols.

Key Points: 
  • Strata Identity , the Identity Orchestration company, today announced a new Microsoft Identity Cookbook, which includes several Orchestration Recipes that manage the complex identity relationships and processes for moving Windows applications from Microsoft Active Directory (AD) to cloud-based Microsoft Entra ID and extending Microsoft Entra ID to on-premises legacy Windows apps that do not support modern cloud identity protocols.
  • Working with Strata’s Maverics Identity Orchestration platform, these identity orchestration recipes enable organizations to securely move authentication from Microsoft AD to Microsoft Entra ID and/or support the coexistence of AD and Entra ID indefinitely.
  • These new orchestration recipes and additional resources addressing Microsoft AD and Microsoft Entra ID application modernization challenges are available on the Strata Microsoft Cookbook page .
  • Modernizing application authentication away from Microsoft AD to Microsoft Entra ID, or extending Entra ID to on-premises apps requires extensive, expensive, and time-consuming rewrites.

Aerospace Avionics Market to Reach $111.58 Billion, Globally, by 2032 at 8.9% CAGR: Allied Market Research

Retrieved on: 
Wednesday, March 20, 2024
Statistics, Panasonic Avionics Corporation, PDF, Growth, Communication, Original equipment manufacturer, EFVS, Airbus, Elbit Systems, Research, STC, Boeing, Aviation, Universal Avionics, Spacecraft, WAM, OEM, 737NG, Thales Group, System, Radar, Safety, Collins Aerospace, Chart, Growth hacking, Table, Airline

PORTLAND, Ore., March 20, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Aerospace Avionics Market, by Subsystem (Flight Management Systems, Flight Control Systems, Health Monitoring Systems, Electrical & Emergency Systems and Communication, Navigation, and Surveillance Systems), Platform (Military Aviation, Commercial Aviation, General Aviation, and Special Mission Aviation), Fit (Retrofit and Forward Fit), and End-Use (OEM and Aftermarket): Global Opportunity Analysis and Industry Forecast, 2022–2032". the global aerospace avionics market size was valued at $48.74 billion in 2022, and is projected to reach $111.58 billion by 2032, registering a CAGR of 8.9% from 2023 to 2032.

Key Points: 
  • Increase in traffic densities, increase in need to utilize RF spectrum, and improved safety nets have elevated the demand for surveillance systems.
  • This upgrade replaces legacy Pro Line 4 avionics with cutting-edge displays and synthetic vision, addressing obsolescence issues, improving operational efficiency, and enhancing safety.
  • Rigorous safety standards and a growing emphasis on aviation cybersecurity are prompting investments in avionics technology, thus driving the market.
  • The aerospace avionics market analysis spans across more than 16 countries, offering a detailed breakdown of each country's value ($million) from 2022 to 2032.

Aerospace Avionics Market to Reach $111.58 Billion, Globally, by 2032 at 8.9% CAGR: Allied Market Research

Retrieved on: 
Wednesday, March 20, 2024
Statistics, Panasonic Avionics Corporation, PDF, Growth, Communication, Original equipment manufacturer, EFVS, Airbus, Elbit Systems, Research, STC, Boeing, Aviation, Universal Avionics, Spacecraft, WAM, OEM, 737NG, Thales Group, System, Radar, Safety, Collins Aerospace, Chart, Growth hacking, Table, Airline

PORTLAND, Ore., March 20, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Aerospace Avionics Market, by Subsystem (Flight Management Systems, Flight Control Systems, Health Monitoring Systems, Electrical & Emergency Systems and Communication, Navigation, and Surveillance Systems), Platform (Military Aviation, Commercial Aviation, General Aviation, and Special Mission Aviation), Fit (Retrofit and Forward Fit), and End-Use (OEM and Aftermarket): Global Opportunity Analysis and Industry Forecast, 2022–2032". the global aerospace avionics market size was valued at $48.74 billion in 2022, and is projected to reach $111.58 billion by 2032, registering a CAGR of 8.9% from 2023 to 2032.

Key Points: 
  • Increase in traffic densities, increase in need to utilize RF spectrum, and improved safety nets have elevated the demand for surveillance systems.
  • This upgrade replaces legacy Pro Line 4 avionics with cutting-edge displays and synthetic vision, addressing obsolescence issues, improving operational efficiency, and enhancing safety.
  • Rigorous safety standards and a growing emphasis on aviation cybersecurity are prompting investments in avionics technology, thus driving the market.
  • The aerospace avionics market analysis spans across more than 16 countries, offering a detailed breakdown of each country's value ($million) from 2022 to 2032.

Liquid Agency and Avasta Release First Installment of Challenger Index

Retrieved on: 
Wednesday, March 6, 2024
Data Management, Technology, Professional Services, Business, Apps, Applications, Software, Networks, Internet, Fintech, Mobile, Wireless, Finance, WAM, Growth, Trust, TAM, Weather, CRM, Agency

Liquid Agency, a brand consulting and activation company, and Avasta, the profitable growth company, published the first installment of their Liquid x Avasta Challenger Index, B2B Products, in Q4 2023.

Key Points: 
  • Liquid Agency, a brand consulting and activation company, and Avasta, the profitable growth company, published the first installment of their Liquid x Avasta Challenger Index, B2B Products, in Q4 2023.
  • Liquid Agency and Avasta co-developed this index to challenge conventional metrics of brand success and gain a clearer understanding of how end-buyers, decision-makers and power users perceive products and services in various categories.
  • Through this unique approach, Liquid Agency and Avasta redefine business strategy through the lens of brand competitiveness.
  • Liquid Agency and Avasta plan to release installments of the index regularly.

Weiss Asset Management is Unrelated to Weiss Multi-Strategy Advisers LLC

Retrieved on: 
Sunday, March 3, 2024
Asset Management, Professional Services, Finance, WAM, Asset management

Weiss Asset Management (“WAM”) is an investment manager based in Boston, Massachusetts founded by academic economist Andrew Weiss.

Key Points: 
  • Weiss Asset Management (“WAM”) is an investment manager based in Boston, Massachusetts founded by academic economist Andrew Weiss.
  • WAM is completely unrelated to Weiss Multi-Strategy Advisers LLC, which is based in New York and was founded by George Weiss.
  • There was a report today that Weiss Multi-Strategy Advisers plans to close operations in the near term.
  • Such closing will have no effect on WAM, which will continue seeking to provide value to its investors.

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

Retrieved on: 
Friday, January 12, 2024
Conference call, Texas Oncology, Cancer, Patient, Conference, Research, WAM

FLORHAM PARK, N.J., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host a conference call with M. Yair Levy, M.D., director of hematologic malignancies research at Texas Oncology and investigator in the CLOVER WaM pivotal study of iopofosine I 131, on Friday, January 19, 2024 at 8:30 a.m.

Key Points: 
  • FLORHAM PARK, N.J., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host a conference call with M. Yair Levy, M.D., director of hematologic malignancies research at Texas Oncology and investigator in the CLOVER WaM pivotal study of iopofosine I 131, on Friday, January 19, 2024 at 8:30 a.m.
  • ET.
  • Dr. Levy will join the Cellectar management team to discuss his perspective, as a community-based hemotologist, on the positive topline results of iopofosine I 131 in patients with relapsed/refractory Waldenstrom’s macroglobulinemia, announced on January 8, 2024.
  • Details for the call are as follows:
    Conference call & Webcast Details:

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

Retrieved on: 
Monday, January 8, 2024
Sequela, Quality of life, Febrile neutropenia, WM, Death, Anemia, International, IWMF, Disease, Neutropenia, NDA, WAM, News, Cancer, Thrombocytopenia, SCR, Macroglobulinemia, MCI, MRR, Mayo Clinic, Mitt, Patient, Safety, Medicine, Cytopenia, Immunoglobulin M, Pharmaceutical industry

The CLOVER WaM study met its primary endpoint with a major response rate (MRR) of 61% (95% confidence interval [44.50%, 75.80%, two-sided p value

Key Points: 
  • The CLOVER WaM study met its primary endpoint with a major response rate (MRR) of 61% (95% confidence interval [44.50%, 75.80%, two-sided p value
  • Notably, iopofosine monotherapy achieved an 8% stringent complete remission (sCR) in this highly refractory WM population.
  • “The results from this pivotal study utilizing just four doses of iopofosine monotherapy in heavily pretreated patients are very compelling, demonstrating deep and durable remissions.
  • “Iopofosine’s high major response rate and achievement of the study’s primary endpoint in highly refractory, Waldenstrom’s macroglobulinemia patients exhibits its potentially practice-changing clinical profile.

Ocean Power Technologies, Inc. Announces Second Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, December 13, 2023
Paragon, Telephone, Government, Primary energy, Conference, CFO, Research, RET, OPT, Controller, Build automation, Calendar, WAM, Letter, Growth, Ocean Power Technologies, Investment, Intelligence, Unitary state

MONROE TOWNSHIP, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT), today announced financial results for its fiscal second quarter ended October 31, 2023 (“Q224”), including year-over-year revenue, gross profit, and pipeline growth.

Key Points: 
  • MONROE TOWNSHIP, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT), today announced financial results for its fiscal second quarter ended October 31, 2023 (“Q224”), including year-over-year revenue, gross profit, and pipeline growth.
  • Revenues of $0.9 million for Q224 grew $0.6 million over revenues of $0.3 million for the fiscal quarter ended October 31, 2022 (“Q223”).
  • The gross margin rate was 53.3% and 22.9%, for the six months ended October 31, 2023, and 2022, respectively.
  • Due to demand, production is already underway to fulfill the order in alignment with the delivery schedule and will allow for revenue recognition this fiscal year.

Marshall Islands, a nation at the heart of global shipping, fights for climate justice

Retrieved on: 
Monday, June 26, 2023
Zero, Review, Paris, Marshall, United Nations, West Coast of the United States, Industry, Climate, Life, International Maritime Organization, World Bank Group, Woman, Research, 1957 Paris summit, WAM, Carbon, World Bank, Ministry, Man, Climate change, IMO, Developed country, Corporation, Island, Marshall Islands, United Kingdom, Death, List, Shipbuilding, Tourism, Coal, Renewable energy, Pacific Ocean, Education

On board were Alson Kelen, founder of Waan Aelõñ in Majel (WAM, Canoes of the Marshall Islands), and a group of youngsters taking part in a climate justice workshop.

Key Points: 
  • On board were Alson Kelen, founder of Waan Aelõñ in Majel (WAM, Canoes of the Marshall Islands), and a group of youngsters taking part in a climate justice workshop.
  • Sailing ships, some finished and some under construction, surround an A-frame building right between the government-owned Marshall Islands Resort and the Ministry of Education on Majuro Atoll.
  • As home to the world’s third-largest ship registry, the Marshall Islands is a key player in global shipping, while rising sea levels threaten its low-lying islands.

What’s at stake?

    • Shipping emissions add up to around 1 billion tonnes a year.
    • In 2018, the International Maritime Organization (IMO), the United Nations agency that regulates shipping, set its first sector-wide climate target: to halve shipping emissions between 2008 and 2050.
    • This “initial strategy” doesn’t align with the Paris Agreement goal of keeping global warming below 1.5℃.
    • Read more:
      Shipping emissions must fall by a third by 2030 and reach zero before 2050 – new research

How can the energy transition be made equitable?

    • Pacific states are also calling for an equitable energy transition.
    • In 2021, the Marshall Islands proposed a global levy on shipping emissions – at least US$100 per tonne of CO₂-equivalent – to speed up the transition.
    • Shipping costs will go up as the energy transition unfolds.
    • For small island developing states like the Marshall Islands, not getting help with these costs could prove disastrous.

‘We are not drowning. We are fighting’

    • It will raise enormous revenues, leading to questions of how to administer and spend these funds.
    • The World Bank is positioning itself to administer the US$3.7 trillion that may be levied over the decades to 2050.
    • The shipping industry, they whisper in the corridors of the International Maritime Organization, can’t be expected to solve all the world’s problems.
    • The most ambitious “equitable transition” now on the table will barely fix centuries of colonial exploitation and unfair trade.